The molecular genetics of X-linked lymphoproliferative (duncan's) disease

Cancer Journal from Scientific American

Volumn 5, Issue 2, 1999, Pages 57-62

  Sumegi, Janos ^a,b   Gross, Thomas G ^a   Seemayer, Thomas A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ETOPOSIDE;

AMINO ACID SEQUENCE; ARTICLE; EPSTEIN BARR VIRUS; GENE LOCUS; GENE MAPPING; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR GENETICS; NONHODGKIN LYMPHOMA; PERSISTENT VIRUS INFECTION; PHENOTYPE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEQUENCE HOMOLOGY; SEQUENCE TAGGED SITE; STEM CELL TRANSPLANTATION; X CHROMOSOME LINKED DISORDER;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; LINKAGE (GENETICS); LYMPHOPROLIFERATIVE DISORDERS; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; X CHROMOSOME;

EID: 0032921193     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Gatti RA, Good RA. Occurrence of malignancy in immunodeficiency diseases. Cancer 1971;28:89-98.
2. Seemayer T A, Gross TG, Egeler RM et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995;38:471-478.
3. Purtillo DT, Yang DT, Casel CK et al. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1975;1:935-950.
4. Gross TG, Filipovich AH, Conley ME et al. Cure of X-linked proliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP Registry. Bone Marrow Transplant 1996;17:741-744.
5. Seemayer TA, Gross TG, Greiner T et al. Update on X-linked lymphoproliferative disease research. Crit Rev Oncol/Hematol 1999; in press.
6. Purtilo DT. Hypothesis: pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrome. Lancet 1976;2:882-885.
7. Purtilo DT, Pacquin L, DeFlorio D et al. Immunodiagnosis and immunopathogenesis of the X-linked recessive lymphoproliferative syndrome. Semin Hematol 1979;16:309-343.
8. Purtilo DT. X-linked lymphoproliferative syndrome: an immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma. Arch Pathol Lab Med 1981;105:119-121.
9. Purtilo DT. Immunopathology of the X-linked lymphoproliferative syndrome. Hamatol Bluttransfus 1981;26:207-214.
10. Thiele G, Bicak M, Grierson H et al. Antibody reactivity to a synthetic peptide (P62) of the Epstein-Barr nuclear antigen in sera of patients with X-linked lymphoproliferative syndrome. J Immunol Methods 1987;100:249-259.
11. Grierson HL, Purtilo DT. Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann Intern Med 1987;106:538-545.
12. Purtilo DT, Sakamoto K, Barnabei V et al. Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry. Am J Med 1982;73:49-56.
13. Purtilo DT, Szymanski I, Bhawan J et al. X-linked recessive lymphoproliferative syndrome. Lancet 1978;1:554.
14. Purtilo DT, DeFlorio D Jr, Hutt LM et al. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. N Engl J Med 1977;297:1077-1080.
15. McKusick VA, Francomano CA, Antonarkis SE et al. Mendelman Inheritance in Man. Catalogs of Autosomal Dominant, Autosomal Recessive and X-Linked Phenotypes. Baltimore: The Johns Hopkins University Press, 1990.
16. Skare JC, Milunsky A, Byron KS et al. Mapping the X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 1987;84:2015-2018.
17. Skare JC, Sullivan JL, Milunsky A et al. Mapping the mutation causing the X-linked lymphoproliferative syndrome in relation to restriction fragment length polymorphisms on Xq. Hum Genet 1989;82:349-353.
18. Skare JC, Grierson HL, Sullivan JL. Linkage analysis of seven kindreds with the X-linked lymphoproliferative syndrome (XLP) confirms that the XLP locus is near DXS42 and DXS37. Hum Genet 1989;82:354-358.
19. Harris A, Lenoir GM, Lankaster SA. X-linked lymphoproliferative disease: linkage studies using DNA probes. Clin Genet 1988;33:162-168.
20. Sylla BS, Wang Q, Hayoz D et al. Multipoint linkage mapping of the Xq25-q26 region in a family affected by the X-linked lymphoproliferative syndrome. Clin Genet 1989;36:459-462.
21. Wang Q, Ishikawa-Brush Y, Monaco AP et al. Physical mapping of Xq24-25 around loci closely linked to the X-linked lymphoproliferative syndrome locus: an overlapping YAC map and linkage between DXS12, DXS42, and DXS37. Eur J Hum Genet 1993;1:64-71.
22. Wyandt HE, Grierson HL, Sanger WG et al. Chromosome deletion of Xq25 in an individual with X-linked lymphoproliferative disease. Am J Med Genet 1989;33:426-430.
23. Sanger WG, Grierson HL, Skare J et al. Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP). Cancer Genet Cytogenet 1990;47:163-169.
24. Skare J, Wu BL, Nelson D et al. Characterization of three overlapping deletions causing X-linked lymphoproliferative disease. Genomics 1993;16:254-255.
25. Wu BL, Milunsky A, Nelson D et al. High-resolution mapping of probes near the X-linked lymphoproliferative (XLP) locus. Genomics 1993;17:163-170.
26. Chromosome X Workshop, Houston, 1995.
27. Lanyi A, Li B, Li S et al. A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus. Genomics 1997;39:55-65.
28. Porta G, MacMillan S, Nagaraja R et al. 4.5-mB YAC STS contig at 50-kb resolution, spanning Xq25 deletions in two patients with lymphoproliferative syndrome. Genome Res 1997;7:27-36.
29. Lamartine J, Nichols KE, Yin L et al. Physical map and cosmid contig encompassing a new interstitial deletion of the X-linked lymphoproliferative syndrome region. Eur J Hum Genet 1996;4:342-351.
30. Bolino A, Yin L, Seri M et al. A new candidate region for the positional cloning of the XLP gene. Eur J Hum Genet 1998;6:509-517.
31. Coffey AJ, Brooksbank RA, Brandau O et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998;20:129-135.
32. Sayos J, Wu C, Morra M et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998;395:462-469.
33. Nichols KE, Harkin DP, Levitz S et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 1998; 95:13765-13770.